HYDRA BIOSCIENCES
Hydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise in novel ion channels. Hydra's proprietary high throughput screening platforms enable the company to identify and develop drug candidates that address significant unmet medical needs. Hydra's ion channel drug discovery program is currently focused on channels implicated in pain, inflammation, and cardiovascula... r disease. Hydra's intellectual property portfolio, significant ion channel expertise, and flexible screening systems set it apart from other biopharmaceutical companies. Unlike classical sodium, calcium, or potassium voltage-gated channels Hydra's novel ion channels provide the potential to develop selective and safer ion channel drugs. Hydra has raised significant financing from blue-chip investors since its inception. This prominent group of investors includes Abingworth Ventures, Advanced Technology Ventures, Polaris Ventures, Lilly Bio Ventures, New Enterprise Associates, BioVentures Investors, Biogen Idec, Boston Medical Investors, and MedImmune Ventures.
HYDRA BIOSCIENCES
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.hydrabiosciences.com
Total Employee:
11+
Status:
Active
Contact:
617-494-5230
Email Addresses:
[email protected]
Total Funding:
94.88 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Microsoft Microsoft Azure Network Solutions DNS Confluence Networks Microsoft Azure US North Region
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Advanced Technology Ventures
Advanced Technology Ventures investment in Series D - Hydra Biosciences
Biogen Idec
Biogen Idec investment in Series D - Hydra Biosciences
Polaris Partners
Polaris Partners investment in Series D - Hydra Biosciences
Abingworth
Abingworth investment in Series D - Hydra Biosciences
MedImmune Ventures
MedImmune Ventures investment in Series D - Hydra Biosciences
Bioventures Investors
Bioventures Investors investment in Series D - Hydra Biosciences
Lilly Ventures
Lilly Ventures investment in Series D - Hydra Biosciences
Lilly Ventures
Lilly Ventures investment in Series C - Hydra Biosciences
Advanced Technology Ventures
Advanced Technology Ventures investment in Series C - Hydra Biosciences
Polaris Partners
Polaris Partners investment in Series C - Hydra Biosciences
Official Site Inspections
http://www.hydrabiosciences.com
- Host name: 208.91.197.27
- IP address: 208.91.197.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Hydra Biosciences"
Hydra Biosciences Company Profile 2024: Valuation, …
Hydra Biosciences General Information Description. Developer of molecular regeneration medicines intended to treat pain, inflammation, anxiety and other diseases. The company's medicines focuses in the field of Transient Receptor …See details»
Hydra Biosciences Information - RocketReach
Hydra Biosciences is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that develops drugs to treat pain, inflammation, renal disease, …See details»
Hydra Biosciences, Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hydra Biosciences, Inc of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Hydra Biosciences, Inc. - VentureRadar
Hydra Biosciences is using its expertise in the recently discovered Transient Receptor Potential (TRP) family of ion channels, together with a proprietary screening platform for these …See details»
Hydra Biosciences - LinkedIn
Hydra Biosciences is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that develops drugs to treat pain, inflammation, renal disease, anxiety and ...See details»
Hydra Biosciences Inc - Company Profile and News
Hydra Biosciences, Inc. operates as a biopharmaceutical company. The Company develops novel drugs to treat pain, renal, inflammation, pulmonary, anxiety, and other diseases. Hydra …See details»
Hydra Biosciences – Funding, Valuation, Investors, News
Jul 6, 2021 Hydra Biosciences is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that develops drugs to treat pain, inflammation, renal …See details»
Hydra Biosciences - Scientist.com
Hydra Biosciences, a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, anxiety and other diseases using its expertise in novel …See details»
Hydra Biosciences Inc. - BioCentury Company Profiles - BCIQ
Oct 2, 2020 Hydra Biosciences Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Robert Carpenter - Chairman @ Hydra Biosciences
Primary Organization . Hydra Biosciences . Gender Male; Robert Carpenter is Chairman of Hydra Biosciences Inc., a company he helped found which is conducting research in a new class of ion channels. Previously, he served as …See details»
Hydra Biosciences - Contacts, Employees, Board Members
Hydra Biosciences has 2 current employee profiles, including Vice President, Chemistry Bert Chenard. Hydra Biosciences has 10 board members and advisors, including Samuel Wu . …See details»
Emerging Drug Developer: Hydra Biosciences | Fierce Biotech
Hydra Biosciences stakes its future on ion channels When Hydra Biosciences announced last week that it had raised $22 million in its Series D round, the developer earmarked much of that …See details»
Hydra Biosciences: Chemistry & Biology - Cell Press
Although Hydra Biosciences is in the business of finding new ways to repair and regenerate injured heart cell tissues, they are not a cell-based therapy company. This means no stem …See details»
Lilly Acquires Hydra Biosciences’ Pain Asset - Pharmasources
Dec 18, 2018 Eli Lilly and Co. has entered an agreement with Hydra Biosciences to acquire all assets related to Hydra's preclinical program of TRPA1 antagonists, part of the Transient …See details»
Hydra Biosciences and Boehringer Ingelheim Announce Worldwide ...
Apr 24, 2014 More information about Hydra Biosciences is available at: www.hydrabiosciences.com. About Boehringer Ingelheim The Boehringer Ingelheim group is …See details»
Hydra Biosciences and Boehringer Ingelheim Enter Research …
Apr 13, 2015 Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other …See details»
Hydra Biosciences and Boehringer Ingelheim announce worldwide ...
Apr 24, 2014 Hydra Biosciences, Inc., a leader in the field of Transient Receptor Potential (TRP) channel modulation, and Boehringer Ingelheim, one of the world’s leading pharmaceutical …See details»
Hydra Biosciences - Abingworth LLP
Hydra Biosciences has applied its leading expertise in Transient Receptor Potential (TRP) channels to discover potential new drugs for the treatment of a range of conditions, including …See details»
Hydra Biosciences and Boehringer Ingelheim collaborate - Drug …
“This new collaboration agreement with Hydra Biosciences reflects the importance and value Boehringer Ingelheim places in developing strong research partnerships to discover new …See details»